Maurice C. Owen

2.1k total citations · 1 hit paper
33 papers, 1.7k citations indexed

About

Maurice C. Owen is a scholar working on Cancer Research, Hematology and Molecular Biology. According to data from OpenAlex, Maurice C. Owen has authored 33 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cancer Research, 12 papers in Hematology and 10 papers in Molecular Biology. Recurrent topics in Maurice C. Owen's work include Protease and Inhibitor Mechanisms (15 papers), Blood Coagulation and Thrombosis Mechanisms (9 papers) and Hemoglobinopathies and Related Disorders (7 papers). Maurice C. Owen is often cited by papers focused on Protease and Inhibitor Mechanisms (15 papers), Blood Coagulation and Thrombosis Mechanisms (9 papers) and Hemoglobinopathies and Related Disorders (7 papers). Maurice C. Owen collaborates with scholars based in New Zealand, United Kingdom and Australia. Maurice C. Owen's co-authors include Robin W. Carrell, Stephen O. Brennan, D. Ross Boswell, Jessica H. Lewis, Lloyd Vaughan, Jan‐Olof Jeppsson, Carl‐Bertil Laurell, Stephen O. Brennan, James Travis and P.M. George and has published in prestigious journals such as Nature, New England Journal of Medicine and Journal of Biological Chemistry.

In The Last Decade

Maurice C. Owen

33 papers receiving 1.6k citations

Hit Papers

Structure and variation of human α1–antitrypsin 1982 2026 1996 2011 1982 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maurice C. Owen New Zealand 16 820 779 619 371 263 33 1.7k
Susan Bock United States 21 490 0.6× 889 1.1× 737 1.2× 177 0.5× 292 1.1× 32 1.8k
Peter R. Elliott United Kingdom 18 877 1.1× 670 0.9× 394 0.6× 333 0.9× 99 0.4× 22 1.7k
Tatiana B. Gasic United States 15 356 0.4× 605 0.8× 628 1.0× 591 1.6× 159 0.6× 21 1.9k
Lydia Santell United States 21 486 0.6× 617 0.8× 483 0.8× 123 0.3× 140 0.5× 31 1.4k
Robert J. Baugh United States 8 402 0.5× 391 0.5× 425 0.7× 133 0.4× 196 0.7× 9 1.1k
B. Carritt United Kingdom 24 259 0.3× 1.0k 1.3× 449 0.7× 331 0.9× 180 0.7× 64 1.9k
Sylvie Giuriato France 21 299 0.4× 1.3k 1.6× 450 0.7× 388 1.0× 183 0.7× 35 2.2k
Tsz Kan Fung Hong Kong 21 308 0.4× 1.5k 1.9× 422 0.7× 506 1.4× 177 0.7× 29 1.9k
Peter R. Strack United States 20 518 0.6× 2.1k 2.7× 211 0.3× 808 2.2× 106 0.4× 34 2.8k
J. Whang‐Peng United States 22 327 0.4× 1.1k 1.4× 456 0.7× 867 2.3× 229 0.9× 46 2.2k

Countries citing papers authored by Maurice C. Owen

Since Specialization
Citations

This map shows the geographic impact of Maurice C. Owen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maurice C. Owen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maurice C. Owen more than expected).

Fields of papers citing papers by Maurice C. Owen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maurice C. Owen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maurice C. Owen. The network helps show where Maurice C. Owen may publish in the future.

Co-authorship network of co-authors of Maurice C. Owen

This figure shows the co-authorship network connecting the top 25 collaborators of Maurice C. Owen. A scholar is included among the top collaborators of Maurice C. Owen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maurice C. Owen. Maurice C. Owen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Owen, Maurice C.. (2015). The glucose vs. HbA1c controversy. Clinicians weigh arguments for both types of diabetes testing.. PubMed. 47(11). 26–7. 1 indexed citations
3.
Brennan, Stephen O., et al.. (2012). Novel haemoglobin mutation (α127Lys → Glu) increases oxygen affinity and has a minor effect on haptoglobin binding. Clinical Biochemistry. 45(18). 1587–1590. 2 indexed citations
4.
Brennan, Stephen O., et al.. (2008). Novel hemoglobin α chain elongation resulting from a 15-residue insertion and tandem duplication of the F helix. Clinical Biochemistry. 41(14-15). 1156–1161. 8 indexed citations
5.
Weber, Alfred, et al.. (2007). Convenient high-resolution isoelectric focusing (IEF) method for the separation of alpha1-proteinase inhibitor (A1PI) isoforms in A1PI concentrates. Journal of Pharmaceutical and Biomedical Analysis. 45(1). 107–111. 5 indexed citations
6.
Pike, Robert N., Jan Potempa, Richard Skinner, et al.. (1997). Heparin-dependent Modification of the Reactive Center Arginine of Antithrombin and Consequent Increase in Heparin Binding Affinity. Journal of Biological Chemistry. 272(32). 19652–19655. 45 indexed citations
7.
Owen, Maurice C., et al.. (1994). Hb Footscray or α133(H16) SER→ARG: A New Hemoglobin Variant. Hemoglobin. 18(1). 19–27. 6 indexed citations
8.
Owen, Maurice C., et al.. (1993). HB Howick [β37(C3)TRP→GLY]: A New High Oxygen Affinity Variant of the α1β2 Contact. Hemoglobin. 17(6). 513–521. 9 indexed citations
9.
Walmsley, T A, et al.. (1992). A competitive ELISA for lipoprotein(a). Clinica Chimica Acta. 205(3). 213–222. 7 indexed citations
11.
Beresford, Charles & Maurice C. Owen. (1990). Antithrombin III. International Journal of Biochemistry. 22(2). 121–128. 24 indexed citations
12.
Owen, Maurice C., G. John Shaw, E Grau, et al.. (1989). Molecular characterization of antithrombin barcelona-2: 47 arginine to cysteine. Thrombosis Research. 55(4). 451–457. 6 indexed citations
13.
Molloy, Christopher J., et al.. (1989). Immunoadsorbent purification of antithrombin: Active form and inactive variants. Thrombosis Research. 55(5). 657–660. 5 indexed citations
14.
Borg, J.Y., Maurice C. Owen, Claudine Soria, et al.. (1988). Proposed heparin binding site in antithrombin based on arginine 47. A new variant Rouen-II, 47 Arg to Ser.. Journal of Clinical Investigation. 81(4). 1292–1296. 64 indexed citations
15.
Owen, Maurice C., Charles Beresford, & Robin W. Carrell. (1988). Antithrombin Glasgow, 393 arg to his: A P1 reactive site variant with increased heparin affinity but no thrombin inhibitory activity. FEBS Letters. 231(2). 317–320. 28 indexed citations
16.
Carrell, Robin W. & Maurice C. Owen. (1985). Plakalbumin, α1-antitrypsin, antithrombin and the mechanism of inflammatory thrombosis. Nature. 317(6039). 730–732. 225 indexed citations
17.
Travis, James, et al.. (1985). Isolation and properties of recombinant DNA produced variants of human alpha 1-proteinase inhibitor.. Journal of Biological Chemistry. 260(7). 4384–4389. 121 indexed citations
18.
Owen, Maurice C., Stephen O. Brennan, Jessica H. Lewis, & Robin W. Carrell. (1983). Mutation of Antitrypsin to Antithrombin. New England Journal of Medicine. 309(12). 694–698. 329 indexed citations
19.
Owen, Maurice C., et al.. (1978). α‐1‐Antitrypsin: Structural relationships of the substitutions of the S and Z variants. FEBS Letters. 88(2). 234–236. 8 indexed citations
20.
Carrell, Robin W., et al.. (1974). Haemoglobin F auckland Gγ7 Asp → Asn: Further evidence for multiple genes for the gamma chain. Biochimica et Biophysica Acta (BBA) - Protein Structure. 365(2). 323–327. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026